Journal ArticleDrugs Real World Outcomes · June 2025
BACKGROUND: Multiple sclerosis (MS) is a heterogeneous disease that may manifest differently among racial/ethnic groups, influencing response to disease-modifying therapy (DMT). Data on natalizumab (NTZ) effectiveness in people with MS (PwMS) based on race ...
Full textLink to itemCite
Journal ArticleJ Womens Health (Larchmt) · March 2025
Objective: To investigate the perceptions of lactation experiences of neurology faculty and the impact of lactation time on academic achievement. Materials and Methods: This was a cross-sectional study utilizing a survey administered across 19 academic neu ...
Full textLink to itemCite
Journal ArticleJ Womens Health (Larchmt) · November 2024
Background: Intersection of gender and race and/or ethnicity in academic medicine is understudied; we aim to understand these factors in relation to scholarly achievements for neurology faculty. Methods: Faculty from 19 US neurology departments completed a ...
Full textLink to itemCite
Journal ArticleInt J MS Care · October 2024
BACKGROUND: Health care utilization is higher in individuals with multiple sclerosis (MS) than in the general population. However, there are limited data on the reasons for their hospital admissions. Our primary objective is to analyze the reasons for the ...
Full textLink to itemCite
Journal ArticleJ Neurol Sci · May 15, 2024
Sarcoidosis is a disease characterized by non-caseating granulomas that can involve the central nervous system as neurosarcoidosis. This challenging disease is currently managed with high dose steroids, and sometimes the addition of infliximab. Other TNA-a ...
Full textLink to itemCite
Journal ArticleNeurol Clin Pract · April 2024
PURPOSE OF REVIEW: Lack of consistent data and guidance have led to variations between clinicians in the management of pregnancy in women with multiple sclerosis (MS). Pregnant and/or lactating women are often excluded from clinical trials conducted in MS, ...
Full textLink to itemCite
Journal ArticleBMJ Neurol Open · 2024
BACKGROUND: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis has been recognised to present with the syndrome of catatonia. In severe cases dysautonomia is representative of malignant catatonia. The treatment with benzodiazepines (BZDs) and electroco ...
Full textLink to itemCite
Journal ArticleObstet Gynecol · December 1, 2023
OBJECTIVE: To investigate the efficacy of cryocompression therapy to prevent chemotherapy-induced peripheral neuropathy. METHODS: This single-institution, randomized, self-controlled trial of cryocompression enrolled gynecologic cancer patients planned for ...
Full textLink to itemCite
Journal ArticleJ Neuroimmunol · August 15, 2023
Sarcoidosis is a granulomatous inflammatory disease that rarely affects the central nervous system as neurosarcoidosis. Neurosarcoidosis can affect any part of the nervous system causing a wide variety of clinical presentations ranging from seizures to opt ...
Full textLink to itemCite
Journal ArticleCurr Allergy Asthma Rep · July 2023
PURPOSE OF REVIEW: Neurosarcoidosis is a rare manifestation of sarcoidosis that is challenging to diagnose. Biopsy confirmation of granulomas is not sufficient, as other granulomatous diseases can present similarly. This review is intended to guide the cli ...
Full textLink to itemCite
Journal ArticleMult Scler Relat Disord · January 2023
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neurological disorder associated with antibodies to aquaporin-4 (AQP4). NMOSD has been thought to follow a progressive disease course, with step-wise accumulation of disability ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Neuroimmunol · December 15, 2022
BACKGROUND/INTRODUCTION: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a chronic demyelinating disorder that has been increasingly recognized since the serum antibody became commercially available in 2017. The most common clini ...
Full textOpen AccessLink to itemCite
Journal ArticleNeurol Clin Pract · August 2021
Management of multiple sclerosis and neuroimmunologic disorders has become increasingly complex because of the expanding number of recognized neuroimmune disorders, increased number of therapeutic options, and multidisciplinary care management needs of peo ...
Full textLink to itemCite
Journal ArticleCurrent Treatment Options in Neurology · June 1, 2021
Purpose of review: This review offers a look into available treatment strategies for patients with MOG-IgG associated disease (MOG-AD). We will focus on evidence-based management options in the acute setting. We will also present recommendations for initia ...
Full textCite
Journal ArticleNeurohospitalist · January 2021
Hospital neurologists participate at the forefront of managing fulminant acute and subacute onset epilepsy, frequently attributed to autoimmune encephalitis (AE). As the recognition of antibody-mediated AE grows, there is a growing number of patients who a ...
Full textLink to itemCite
Journal ArticleTher Adv Neurol Disord · 2020
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous system disorder that is more common in women, with onset often during reproductive years. The female:male sex ratio of MS rose in several regions over the last century, sug ...
Full textLink to itemCite
Journal ArticleJ Neuroimmunol · December 15, 2019
OBJECTIVES: To describe the clinical presentation of MOG antibody disease (MOG-AD) in a series of patients at a single academic center. METHODS: We performed a retrospective review of patients with MOG antibodies. RESULTS: We review the clinical presentati ...
Full textLink to itemCite
Journal ArticleMult Scler Relat Disord · August 2019
Multiple sclerosis (MS) is a chronic autoimmune condition primarily affecting young adults. As there are numerous uncertainties faced by young women of childbearing age who are living with this chronic condition and the gender ratio is increasingly skewed ...
Full textLink to itemCite
Journal ArticleMult Scler Relat Disord · November 2018
BACKGROUND: Acute disseminated encephalomyelitis has been understood as a monophasic, often post-infectious illness that predominantly affects the pediatric population. Though that describes the majority of cases, exceptions do exist. In this case report, ...
Full textOpen AccessLink to itemCite
Journal ArticleCase Rep Neurol Med · 2018
Immune checkpoint inhibitors have improved patient survival outcomes in a variety of advanced malignancies. However, they can cause a number of immune-related adverse effects (irAEs) through lymphocyte dysregulation. Central nervous system (CNS) irAEs are ...
Full textOpen AccessLink to itemCite
Journal ArticleCase Rep Oncol · 2018
Recently, immune checkpoint inhibitors have revolutionized cancer care by enhancing anti-tumor immunity. However, by virtue of stimulating the immune system, they can lead to immune-related adverse events (irAEs). Neurologic irAEs are uncommon but are beco ...
Full textOpen AccessLink to itemCite